| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |